Cary Street Partners Asset Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-407
Closed -$80.3K 308
2023
Q1
$80.3K Hold
407
0.02% 209
2022
Q4
$82.4K Hold
407
0.02% 227
2022
Q3
$72K Buy
+407
New +$83.3K 0.02% 201
2021
Q2
Sell
-1,147
Closed -$251K 172
2021
Q1
$251K Buy
+1,147
New +$230K 0.06% 154

Other funds holding LH

Cary Street Partners Asset Management's LH Position: Q2 2023 in Review

Cary Street Partners Asset Management sold out of Labcorp (LH) in Q2 2023, closing a stake of 407 shares — an estimated $80.3K sold.

Cary Street Partners Asset Management first reported a position in LH in Q1 2021 and held it in 4 quarters. The position peaked at $251K in Q1 2021. 933 funds tracked by Wall St. Rank hold LH as of Q2 2023.

  • Cary Street Partners Asset Management reported no remaining Labcorp position as of Q2 2023 after selling out during the quarter.
  • Cary Street Partners Asset Management sold 407 Labcorp shares in Q2 2023, an estimated $80.3K.
  • Cary Street Partners Asset Management first reported a position in Labcorp in Q1 2021 and held it in 4 quarters.
  • Cary Street Partners Asset Management's Labcorp position peaked at $251K in Q1 2021.
  • 933 funds tracked by Wall St. Rank held Labcorp as of Q2 2023.

Based on Cary Street Partners Asset Management's 13F filing for Q2 2023, filed 10 Aug 2023.